Povidone-iodine (CAS NO : 25655-41-8)

Povidone-iodine (CAS No: 25655-41-8) remains a foundational antimicrobial complex in the global pharmaceutical landscape, with its market valuation projected to reach approximately USD 319.3 million by 2035 as it maintains a dominant 39% share in the skin sterilisation segment. The industry is currently navigating a shift towards high-purity 10% solution concentrations, which command over 58% of the market share due to their critical efficacy in surgical hand scrubbing and chronic wound management for MRSA and biofilm control. Strategic procurement is increasingly influenced by the stability of the raw iodine and polyvinylpyrrolidone (PVP) supply chain, particularly as the Asia Pacific region emerges as a primary growth engine with an anticipated CAGR exceeding 5.5%. As a globally established Povidone-iodine supplier with 9.0% - 12.0% available iodine purity. We ensure dependable supply, consistent quality, and complete regulatory documentation, including Povidone-iodine CoA and Povidone-iodine TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.